Gowling WLG advised AstraZeneca on exclusive option and global license agreement with Pinetree Therapeutics. AstraZeneca has entered into an exclusive option and global license agreement with...
You must be a Standard 1 Year member to access this content.
Gowling WLG advised Oxford BioTherapeutics on the deal. Oxford BioTherapeutics on a global commercial license agreement with a biotech company to advance the development of a...
You must be a Standard 1 Year member to access this content.
Gowling WLG advised Oxford BioTherapeutics on the deal. Oxford BioTherapeutics on a global commercial license agreement with a biotech company to advance the development of a...
You must be a Standard 1 Year member to access this content.
Gowling WLG advised Oxford BioTherapeutics on the deal. Ropes & Gray advised ImmunoGen on this new collaboration. Oxford BioTherapeutics on a multi-year collaboration with ImmunoGen, Inc....
You must be a Standard 1 Year member to access this content.
Gowling WLG has advised Amphista Theraperutics on the deal. Baker Mackenzie advised Bristol Myers Squibb. The deal is a strategic collaboration and license agreement with Bristol...
You must be a Standard 1 Year member to access this content.
Gowling WLG has advised Amphista Theraperutics on the deal. The deal concerns an agreement with Merck Healthcare to collaborate in developing novel protein degrading therapeutics in...
You must be a Standard 1 Year member to access this content.
Gowling WLG advised Swedish pharmaceutical company Immedica Pharma AB on the deal. Immedica signed a licence and supply agreement with Actinium Pharmaceuticals, Inc to commercialise Iomab-B, an...
You must be a Standard 1 Year member to access this content.
Gowling WLG advised AstraZeneca on the transaction. AstraZeneca started a collaboration with Scorpion Therapeutics, Inc. (“Scorpion”) to develop precision medicines against previously hard-to-target cancer proteins. Scorpion will...
You must be a Standard 1 Year member to access this content.
Gowling WLG advised HydrogenOne Capital Growth plc on the deal. HydrogenOne Capital Growth made a £10 million investment in HiiROC Limited (“HiiROC”), a supplier of clean hydrogen production...
You must be a Standard 1 Year member to access this content.
Gowling WLG advised Eisai Co., Ltd. on the deal. Morgan Lewis advised Advanz Pharma. Eisai Co., Ltd. agreed to divest its rights for the antiepileptic agent...
You must be a Standard 1 Year member to access this content.
Gowling WLG advised Britannia Bud Canada Holdings Inc., trading as Britannia Life Sciences in respect of its strategic partnership with a UK laboratory services provider. BLS...
You must be a Standard 1 Year member to access this content.
